Pharmacogenomic-Guided Care May Improve Clinical Outcomes in MDD
Weighted and combined multi-gene pharmacogenomic testing significantly increased clinical response and remission rates for patients with major depressive disorder.
All articles by Kwamesha Joseph
Empagliflozin Effectively Reduces Risk for Heart Failure Hospitalization
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
Next post in Cardiovascular Disease Information Center
